PRESS RELEASE published on 09/23/2024 at 22:30, 1 year 10 months ago DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial DBV Technologies completes screening for VITESSE Phase 3 Clinical Trial evaluating Viaskin Peanut Patch in peanut allergic children ages 4-7. Topline results expected Q4 2025 Clinical Trial DBV Technologies Food Allergies VITESSE Phase 3 Viaskin Peanut Patch
BRIEF published on 09/04/2024 at 22:35, 1 year 11 months ago DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment DBV Technologies Allergies Alimentaires Viaskin Conférence H.C. Wainwright Immunothérapie Épicutanée
BRIEF published on 09/04/2024 at 22:35, 1 year 11 months ago DBV Technologies to Participate in 26th Annual HC Wainwright Global Investment Conference DBV Technologies Viaskin Food Allergies HC Wainwright Lecture Epicutaneous Immunotherapy
PRESS RELEASE published on 09/04/2024 at 22:30, 1 year 11 months ago DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment DBV Technologies participera à la 26e conférence annuelle H.C. Wainwright Global Investment avec Daniel Tassé, Directeur Général, discutant lors d'une session 'Fireside Chat' à New York Biopharmaceutique Conférence Annuelle DBV Technologies Allergies Alimentaires Investissement Global
PRESS RELEASE published on 09/04/2024 at 22:30, 1 year 11 months ago DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference DBV Technologies to participate in H.C. Wainwright 26th Annual Global Investment Conference with CEO Daniel Tassé in New York City. Focus on food allergy treatment and immunotherapy Immunotherapy DBV Technologies Food Allergies H.C. Wainwright Conference VIASKIN Patch
BRIEF published on 08/02/2024 at 22:35, 2 years ago DBV Technologies : Informations au 31 juillet 2024 sur le nombre d'actions et de droits de vote Droits De Vote Capital Social AMF DBV Technologies NYSE Euronext Paris
BRIEF published on 08/02/2024 at 22:35, 2 years ago DBV Technologies: Information as of July 31, 2024 on the number of shares and voting rights Share Capital Voting Rights AMF DBV Technologies NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 2 years ago Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 juillet 2024 Nombre total des droits de vote et d’actions au 31 juillet 2024 pour NYSE Euronext Paris (Code ISIN: FR 0010417345) : 96 498 927 actions, 96 214 457 droits de vote Autorité Des Marchés Financiers Droits De Vote Capital Social Actions NYSE Euronext Paris
PRESS RELEASE published on 08/02/2024 at 22:30, 2 years ago Information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2024 Details of total voting rights and shares of the Company as of July 31, 2024 under AMF regulations Voting Rights Shares AMF Regulations Company July 31 2024
Published on 08/11/2026 at 00:40, 5 hours 51 minutes ago CORRECTION FROM SOURCE: Fermi Announces Binding Lease Agreement with TensorWave
Published on 08/11/2026 at 00:25, 6 hours 6 minutes ago Empress Reports 2026 Second Quarter Financial Results
Published on 08/10/2026 at 23:35, 6 hours 56 minutes ago NioCorp Project to Expand Production to 8 Made-in-USA Critical Minerals Over a 40-Year Mine Life with an Estimated $4.1 Billion Pre-Tax NPV8%
Published on 08/10/2026 at 23:30, 7 hours 1 minute ago Condor and Element79 Agree on Restructured Terms for Lucero Project
Published on 08/10/2026 at 23:25, 7 hours 6 minutes ago Ur-Energy Reports Second Quarter 2026 Results
Published on 08/10/2026 at 22:15, 8 hours 16 minutes ago Amrize Files Form 10-Q for Second Quarter 2026
Published on 08/10/2026 at 22:05, 8 hours 26 minutes ago Immunic Appoints Elena Ridloff to Board of Directors
Published on 08/10/2026 at 20:24, 10 hours 7 minutes ago EQS-Adhoc: PNE AG updates on ongoing sales process
Published on 08/10/2026 at 19:35, 10 hours 56 minutes ago Kontron AG: All conditions of the mandatory tender offer of Ennoconn Corporation are met – Settlement will take place shortly
Published on 08/10/2026 at 19:00, 11 hours 31 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 03 AOUT 2026 au 07 AOUT 2026
Published on 08/10/2026 at 18:00, 12 hours 31 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 12 hours 31 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 12 hours 46 minutes ago Déclaration hebdomadaire de rachat d'actions
Published on 08/10/2026 at 11:53, 18 hours 37 minutes ago GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
